These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 23135290
1. Thymoquinone blocks pSer/pThr recognition by Plk1 Polo-box domain as a phosphate mimic. Yin Z, Song Y, Rehse PH. ACS Chem Biol; 2013 Feb 15; 8(2):303-8. PubMed ID: 23135290 [Abstract] [Full Text] [Related]
2. Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high Plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in HeLa cells. Qian WJ, Park JE, Lim D, Lai CC, Kelley JA, Park SY, Lee KW, Yaffe MB, Lee KS, Burke TR. Biopolymers; 2014 Nov 15; 102(6):444-55. PubMed ID: 25283071 [Abstract] [Full Text] [Related]
3. Exploring the binding nature of pyrrolidine pocket-dependent interactions in the polo-box domain of polo-like kinase 1. Murugan RN, Ahn M, Lee WC, Kim HY, Song JH, Cheong C, Hwang E, Seo JH, Shin SY, Choi SH, Park JE, Bang JK. PLoS One; 2013 Nov 15; 8(11):e80043. PubMed ID: 24223211 [Abstract] [Full Text] [Related]
12. Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugs. Qian WJ, Park JE, Lim D, Park SY, Lee KW, Yaffe MB, Lee KS, Burke TR. Chem Biol; 2013 Oct 24; 20(10):1255-64. PubMed ID: 24120332 [Abstract] [Full Text] [Related]
16. A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1. Reindl W, Strebhardt K, Berg T. Anal Biochem; 2008 Dec 15; 383(2):205-9. PubMed ID: 18793607 [Abstract] [Full Text] [Related]